Search
Search Funnelback University
- Refined by:
- Date: 2022
71 -
80 of
230
search results for `news stories`
Fully-matching results
-
Rat IgG2b monoclonal antibody NORIg 7.16.2
https://www.enterprise.cam.ac.uk/reagents/rat-igg2b-monoclonal-antibody-norig-7-16-2/
9 May 2022:
Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mouse monoclonal antibodies.
-
Mouse CD18 monoclonal antibody YTS 213.1.1
https://www.enterprise.cam.ac.uk/reagents/mouse-cd18-monoclonal-antibody-yts-213-1-1/
9 May 2022:
Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are rat monoclonal antibodies of the IgG2a isotype.
-
FcgRIIIa 158F/GPI receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgriiia-158fgpi-receptor-expressing-cell-line/
9 May 2022:
CHO cells transfected to express human FcgRIIIa of the 158F allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.
-
FcgRIIIa 158V/GPI receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgriiia-158vgpi-receptor-expressing-cell-line/
9 May 2022:
CHO cells transfected to express human FcgRIIIa of the 158V allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.
-
KARPAS 45 Human T-cell Leukaemia cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-45-human-t-cell-leukaemia-cell-line/
9 May 2022:
KARPAS 45 Human T-cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.
-
KARPAS 353 Human B-cell Leukaemia cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-353-human-b-cell-leukaemia-cell-line/
9 May 2022:
KARPAS 353 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.
-
KARPAS 231 Human B-cell Leukaemia cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-231-human-b-cell-leukaemia-cell-line/
9 May 2022:
KARPAS 231 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.
-
Impact Insight video case study: Versed AI – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-versed-ai/
15 Mar 2022:
The second in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Versed AI.
-
Mouse Thy-1 monoclonal antibody YBM 29.2.1
https://www.enterprise.cam.ac.uk/reagents/mouse-thy-1-monoclonal-antibody-ybm-29-2-1/
9 May 2022:
Hybridoma cell line producing YBM 29.2.1antibodies raised against mouse Thy-1, which are rat monoclonal antibodies of the IgG2c isotype.
-
Sharp graphite tips for nanotechnology applications – Cambridge…
https://www.enterprise.cam.ac.uk/reagents/sharp-graphite-tips-for-nanotechnology-applications/
9 May 2022:
Sharp graphite tips have been developed in the lab of Dr Amalio Fernandez-Pacheco at the University of Cambridge using a three-step polishing method.
9 May 2022:
Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mouse monoclonal antibodies.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.